Milestone Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
346
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
MIST
Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. The company's lead investigational product is etripamil, a novel, fast-acting calcium channel blocker delivered as a nasal spray. This formulation is designed for patient self-administration to terminate episodes of certain heart rhythm disturbances outside of a hospital or emergency department setting. The primary indications under investigation for etripamil are paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR), aiming to address unmet needs for acute, at-home treatment of these episodic conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | |
| 8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | |
| 10-Q - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | |
| SCHEDULE 13G/A - Milestone Pharmaceuticals Inc. (0001408443) (Subject) | 2026-03-26 | English | |
| 3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer) | 2026-03-23 | English | |
| 8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-03-20 | English |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45772669 | S-3 - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | ||
| 45561982 | 8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | ||
| 45558367 | 10-Q - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-05-13 | English | ||
| 33052631 | SCHEDULE 13G/A - Milestone Pharmaceuticals Inc. (0001408443) (Subject) | 2026-03-26 | English | ||
| 33016867 | 3 - Milestone Pharmaceuticals Inc. (0001408443) (Issuer) | 2026-03-23 | English | ||
| 32998631 | 8-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-03-20 | English | ||
| 32998457 | 10-K - Milestone Pharmaceuticals Inc. (0001408443) (Filer) | 2026-03-20 | English | ||
| 29473554 | 4/A Filing | 2026-02-05 | English | ||
| 29471051 | 4/A Filing | 2026-02-05 | English | ||
| 29470993 | 4/A Filing | 2026-02-05 | English | ||
| 29470829 | 4/A Filing | 2026-02-05 | English | ||
| 29470753 | 4/A Filing | 2026-02-05 | English | ||
| 29473607 | 4 Filing | 2026-02-04 | English | ||
| 29470850 | 4 Filing | 2026-02-04 | English | ||
| 29470788 | 4 Filing | 2026-02-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Helixmith Co., Ltd
A biotechnology company specializing in the research and de…
|
084990 | KR | Manufacturing |
|
Hemab Therapeutics Holdings, Inc.
Developing novel prophylactic therapeutics for serious, und…
|
COAG | US | Manufacturing |
|
HEMOGENYX PHARMACEUTICALS PLC
Develops cell-based therapies for blood, autoimmune disease…
|
HEMO | GB | Manufacturing |
|
Hempfusion Wellness Inc.
Sells broad-spectrum CBD and probiotic supplements in the h…
|
CBDHF | CA | Manufacturing |
|
HEM Pharma Inc.
Develops microbiome-based healthcare solutions, products, a…
|
376270 | KR | Manufacturing |
|
Hemp Health Spolka Akcyjna
Manages a supply chain for medical marijuana, from cultivat…
|
HMP | PL | Manufacturing |
|
Hempsana Holdings
Specialized manufacturer of cannabis derivatives, extracts,…
|
HMPS | CA | Manufacturing |
|
Henan Lingrui Pharmaceutical Co., Ltd
Produces transdermal drug delivery systems, rubber plasters…
|
600285 | CN | Manufacturing |
|
Henan Taloph Pharmaceutical Stock Co.,Ltd
Researches and produces TCM and chemical drugs for respirat…
|
600222 | CN | Manufacturing |
|
Hengrui Pharma
Global pharmaceutical firm focused on R&D for oncology and …
|
600276 | CN | Manufacturing |
Milestone Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/9643/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=9643 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=9643 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=9643 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 9643}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Milestone Pharmaceuticals Inc. (id: 9643)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.